Drawing for X-MAN

USPTO serial 77582326

X-MAN

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
JOHNSON, AISHA CLARKE
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with X-MAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erica W. Stump

ERICA W. STUMP VITAL PHARMACEUTICALS, INC.15751 SW 41ST STREET#300DAVIE, FL 33331-1520

Goods and services

ClassDescriptionStatusFirst use
032Energy drinks; Isotonic drinks; Sports drinksABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 15, 2009MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
May 15, 2009ABN5ABANDONMENT - AFTER PUBLICATION
May 8, 2009EXARTEAS EXPRESS ABANDONMENT RECEIVED
Feb 24, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Feb 17, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2009NPUBNOTICE OF PUBLICATION
Jan 13, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 13, 2009ALIEASSIGNED TO LIE
Dec 28, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2008DOCKASSIGNED TO EXAMINER
Oct 3, 2008NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance